Steven A Cornelissen

Vizgen, Inc., located in Cambridge, MA, is at the forefront of spatial genomics, offering innovative solutions such as the MERSCOPE Ultra system and MERFISH technology. Their platforms enable researchers to capture high-resolution spatial transcriptomics and gain insights into cellular functions and interactions with unmatched clarity and scalability. Incorporating advanced technology for tumor profiling and neuroscience applications, Vizgen's merger with Ultivue brings together expertise in transcriptomics and proteomics, enhancing multi-omic research capabilities. This integrated approach empowers scientists to explore the spatial organization of genes and proteins, advancing the understanding of tissue structure and function. Generated from the website

LyteChip Inc. is a fabless silicon photonics company based in Newtonville, MA, specializing in the design of chip-scale miniaturized spectrometers. Their innovative Digital Fourier Transform spectrometer utilizes unique exponential scaling to deliver high performance in an extremely compact form factor. Targeting various industries, LyteChip's technology enables accurate monitoring of volatile organic compounds in oil and gas applications, as well as in-line chemical analysis for pharmaceuticals and agrochemicals. Their products also support advancements in medical diagnostics, specifically in optical coherence tomography (OCT) devices. Generated from the website

Nova Biomedical, based in Waltham, MA, specializes in the development, manufacturing, and sale of advanced analyzers across various healthcare sectors, including hospitals, critical care, and veterinary applications. The company's innovative product lineup features glucose and lactate monitoring systems, blood gas analyzers, and comprehensive solutions for cell culture analysis. Recently merged with Advanced Instruments, Nova Biomedical is committed to enhancing point-of-care testing and providing accurate results for medical professionals. The company continues to expand internationally, with significant investments in new technologies and global sales initiatives. Generated from the website